[ad_1]
In his presentation to the Catholic University of Chile, Egaña, doctor of human biology and pharmacology, explained that after eight years of badyzes and tests on animals (rats, pigs and fish), he would begin the first clinical trial in Salvador, Santiago, with twenty traumatized patients.
"This step, which will last six months, is small but very important to demonstrate the safety of the technology.If we can make it safe, we can apply it to other types of patients and patients. diseases, such as organ transplants and cancer patients, "Egaña told Efe.
This research, carried out at the Catholic University of Chile, was developed a first technique to perform a skin graft by implantation of genetically modified microalgae in order to produce oxygen and thus regenerate the region.
"90% of our body's cells are not human The human body is a real ecosystem where microorganisms and human cells coexist What we want to know is what happens in the body if we plant microalgae that produce photosynthesis, "Egaña said during the presentation.
Photosynthesis is the process that plants perform when they break water molecules, with the energy of light, and release the oxygen that is consumed by all living things on the planet. Chilean scientist.
"The big question is what can we do if man succeeds in reproducing this process in a therapeutic context, because many diseases are caused due to lack of oxygen such as blood pressure? hemorrhage, infarction or large wounds that do not heal, "added Egaña.
The first line of research focuses on possible applications of this technique in wounds to oxygenate them through creams, bandages or sutures containing microorganisms that perform photosynthesis.
While the second line examines the application of this technique. nology in organ transplants, to prolong the life of organs outside the body, and in oncology therapies to achieve greater elimination of cancer cells.
Early research at the University of Lübeck, Germany. , where Egaña got his doctorate, he managed to develop a test in which he injected a fish embryo, a micro-algae, and succeeded in its fusion "without the kelp killing the embryo and that the Embryo does not kill algae ".
As the researcher pointed out today, the key to this first clinical trial will be precisely to avoid the rejection of patients at these transplants.
If the twenty patients correctly receive the skin graft, the idea is that when the skin is regenerated, the implant is removed by the same body or removed.
In this sense, the next six months will be essential in determining the possible implementation will have this technique in the future of medicine. EFE
[ad_2]
Source link
